Published in N Engl J Med on April 14, 1977
A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest (1985) 2.26
Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation (1998) 1.77
Prognostic value of exercise tolerance testing in asymptomatic chronic nonischemic mitral regurgitation. Am J Cardiol (2007) 1.44
Cardiac function at rest and during exercise in normals and in patients with coronary heart disease: evaluation by radionuclide angiocardiography. Ann Surg (1978) 1.30
Coronary bypasses. Br Med J (Clin Res Ed) (1983) 1.07
Effect of oral propranolol on rest and exercise left ventricular ejection fraction, volumes, and segmental wall motion in patients with angina pectoris. Assessment with equilibrium gated blood pool imaging. Br Heart J (1981) 1.04
Predictive value and limitations of the ST/HR slope. Br Heart J (1985) 0.91
Exercise digital subtraction ventriculography for the detection of ischaemic wall motion abnormalities in patients without myocardial infarction. Br Heart J (1986) 0.88
Evidence for emotionally-induced coronary arterial spasm in patients with angina pectoris. Br Heart J (1980) 0.86
Regional left ventricular wall motion from first-pass radionuclide angiocardiography using an Anger camera. Experimental and clinical study. Br Heart J (1980) 0.85
Relation between coronary anatomy and serial changes in left ventricular function on exercise: a study using first pass radionuclide angiography with gold-195m. Br Heart J (1986) 0.84
Effect of glyceryl trinitrate on echocardiographic left ventricular dimensions during exercise in the upright position. Br Heart J (1979) 0.84
Radionuclide angiocardiography, a noninvasive method for evaluating left ventricular ejection fraction and regional wall motion; comparison with contrast left ventricular angiography. Can Med Assoc J (1978) 0.83
Exercise first-pass radionuclide ventriculography in detection of coronary artery disease. Br Heart J (1980) 0.82
Nuclear angiography in convalescent phase of myocardial infarction. Serial study of left ventricular performance. Br Heart J (1980) 0.80
Left ventricular function at rest and during exercise in acute hypothyroidism. Br Heart J (1988) 0.80
Improved cardiac function following left ventricular aneurysm resection: pre- and postoperative performance studies in 150 patients. Tex Heart Inst J (1982) 0.80
Non-invasive measurement of left ventricular function in coronary artery disease. Comparison of first pass radionuclide ventriculography, M-mode echocardiography, and systolic time intervals. Br Heart J (1981) 0.78
Effects of coronary artery bypass grafting on left ventricular function assessed by multiple gated ventricular scintigraphy. Br Heart J (1983) 0.78
Use of first-pass radionuclide ventriculography in assessment of wall motion abnormalities induced by incremental atrial pacing in patients with coronary artery disease. Br Heart J (1980) 0.78
Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias. J Clin Invest (1988) 0.78
Sex differences in exercise induced left ventricular dysfunction in patients with syndrome X. Br Heart J (1987) 0.76
Thallium-201 myocardial imaging in evaluation of asymptomatic individuals with ischaemic ST segment depression on exercise electrocardiogram. Br Heart J (1979) 0.76
Quantitative phase analysis in the assessment of coronary artery disease. Br Heart J (1989) 0.75
Radionuclide left ventricular angiography during exercise in ischemic heart disease. Can Med Assoc J (1980) 0.75
Prognostication in patients with coronary artery disease: preliminary results of radionuclide cineangiographic studies. Bull N Y Acad Med (1983) 0.75
Choosing a nuclear medicine study for cardiovascular applications. Tex Heart Inst J (1996) 0.75
Assessment of magnetic resonance velocity mapping of global ventricular function during dobutamine infusion in coronary artery disease. Br Heart J (1995) 0.75
Limitations of radionuclide ventriculography in the non-invasive diagnosis of coronary artery disease. A correlation with right heart haemodynamic values during exercise. Br Heart J (1985) 0.75
Left ventricular function during graded exercise in patients with coronary artery disease and in control subjects. Can Med Assoc J (1981) 0.75
Selection of patients for coronary artery bypass operations. West J Med (1980) 0.75
Evaluation of changes in myocardial perfusion and function on exercise in patients with coronary artery disease by gated MIBI scintigraphy. Br Heart J (1993) 0.75
Nuclear medicine-epitomes of progress: the exercise heart function test. West J Med (1978) 0.75
Rate of change of left ventricular ejection fraction during exercise is superior to the peak ejection fraction for predicting functionally significant coronary artery disease. Br Heart J (1993) 0.75
Exercise first-pass radionuclide ventriculography in detection of coronary artery disease. Br Heart J (1981) 0.75
Studies by echocardiography of regional and global cardiac function during exercise. Trans Am Clin Climatol Assoc (1979) 0.75
Nonischemic mitral regurgitation: prognostic value of nonsustained ventricular tachycardia after mitral valve surgery. Cardiology (2013) 0.75
Implications for anaesthesia of new concepts in cardiovascular diseases: discussion paper. J R Soc Med (1983) 0.75
Comparison of radionuclide and contrast ventriculography for detection and quantitation of regions of myocardial ischemia in dogs. J Clin Invest (1981) 0.75
Implications of neural regulation of the heart in health and disease. Can Med Assoc J (1980) 0.75
Receptor function reserve: a new parameter for disease detection. Eur J Nucl Med Mol Imaging (2004) 0.75
Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res (2004) 6.49
Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation (2004) 6.43
Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med (1990) 5.91
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94
Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise. Circ Res (1966) 3.95
Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med (1984) 3.81
Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med (1991) 3.80
Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation (1996) 3.58
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med (1996) 3.40
Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation (1973) 3.31
Colitis cystica profunda. Am J Clin Pathol (1966) 3.28
Sudden death in young athletes. Circulation (1980) 3.05
The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol (2000) 2.99
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med (1979) 2.86
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol (2001) 2.74
Can coronary flow parameters after stent placement predict restenosis? Cathet Cardiovasc Diagn (1995) 2.69
Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation (1999) 2.67
Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J Am Coll Cardiol (2000) 2.61
Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation (1983) 2.59
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation (1989) 2.56
Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol (1982) 2.54
"Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol (1988) 2.53
A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med (1989) 2.45
Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol (1981) 2.37
Causes of sudden death in competitive athletes. J Am Coll Cardiol (1986) 2.31
Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation (2000) 2.28
Comparative left ventricular dimensions in trained athletes. Ann Intern Med (1975) 2.27
Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol (2001) 2.22
Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol (1986) 2.18
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18
Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation (1976) 2.08
Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation (1991) 2.06
Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Circulation (1997) 2.05
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol (2000) 2.05
Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography. Circulation (1981) 2.00
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol (1984) 1.99
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology (1982) 1.99
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation (1996) 1.99
Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation (1994) 1.98
Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. The NHLBI PTCA Registry. Circulation (1993) 1.98
Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis. N Engl J Med (1973) 1.96
Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med (1979) 1.96
Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation (1975) 1.96
Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol (1995) 1.93
Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv (2001) 1.93
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol (1998) 1.91
Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol (1981) 1.89
Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation (1971) 1.89
Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1993) 1.89
Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation (1982) 1.87
Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation (1974) 1.85
Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. N Engl J Med (1966) 1.83
Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol (1983) 1.82
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81
Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation (1979) 1.80
Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. Am J Cardiol (1978) 1.78
"Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol (1978) 1.76
Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation (1990) 1.72
Rotational coronary atherectomy after unsuccessful coronary balloon angioplasty. Am J Cardiol (1993) 1.71
Quantitative imaging of iodine-124 with PET. J Nucl Med (1996) 1.69
The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis (2000) 1.66
Femoral artery hemostasis using an implantable device (Angio-Seal) after coronary angioplasty. Cathet Cardiovasc Diagn (1996) 1.65
Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol (2000) 1.64
Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation (1992) 1.63
Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol (1979) 1.63
Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study. Eur Heart J (1998) 1.62
Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves. N Engl J Med (1967) 1.61
Limitations of the electrocardiographic response to exercise in predicting coronary-artery disease. N Engl J Med (1975) 1.61
Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation (2001) 1.61
Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol (2000) 1.60
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation (1983) 1.60
Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol (1987) 1.57
Asymetric septal hypertrophy in childhood. Circulation (1976) 1.56
Myocardial adenyl cyclase: activation by thyroid hormones and evidence for two adenyl cyclase systems. J Clin Invest (1969) 1.56
Asymmetric septal hypertrophy (ASH): the unifying link in the IHSS disease spectrum. Observations regarding its pathogenesis, pathophysiology, and course. Circulation (1973) 1.55
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study. Int J Cardiol (2013) 1.55
Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease. J Am Coll Cardiol (1992) 1.55
Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol (1979) 1.55
Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina. A clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation (1993) 1.54
[18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? Circulation (1998) 1.54
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. Circulation (1984) 1.54
Echocardiographic measurement of the left ventricular outflow gradient in idiopathic hypertrophic subaortic stenosis. N Engl J Med (1973) 1.52
Prediction of the frequency and duration of ambulatory myocardial ischemia in patients with stable coronary artery disease by determination of the ischemic threshold from exercise testing: importance of the exercise protocol. J Am Coll Cardiol (1991) 1.52
Exercise-induced ischemia in mildly symptomatic patients with coronary-artery disease and preserved left ventricular function. Identification of subgroups at risk of death during medical therapy. N Engl J Med (1984) 1.51
Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res (1993) 1.51
The diagnosis of acute acalculous cholecystitis: a comparison of sonography, scintigraphy, and CT. AJR Am J Roentgenol (1986) 1.50
Sudden cardiac death without warning. Possible mechanisms and implications for screening asymptomatic populations. N Engl J Med (1989) 1.50
Measurement of mitral orifice area in patients with mitral valve disease by real-time, two-dimensional echocardiography. Circulation (1975) 1.49
Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera. Eur J Nucl Med (1992) 1.48